Roche Presents Phase III Trontinemab Data at AAIC
BASEL, Switzerland, July 7, 2026 Roche announced that it will present extensive new clinical and diagnostic data from its...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
BASEL, Switzerland, July 7, 2026 Roche announced that it will present extensive new clinical and diagnostic data from its...
Lille, France; Cambridge, Massachusetts, United States; and Zurich, Switzerland, July 2, 2026 GENFIT announced that U.S. Medicare has approved...
BETHESDA, Md., July 1, 2026 A National Institutes of Health (NIH)-funded study has identified a promising blood-based biomarker that...
SAN DIEGO, May 22, 2026 ClearNote Health announced that it will present new multi-cohort validation data for its Avantect®...
SUZHOU, China, May 6, 2026 Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB announced the achievement of...
IRVINE, Calif., May 6, 2026 Helio Genomics announced publication of landmark clinical data demonstrating that its HelioLiverâ„¢ multi-analyte blood...
ST. PAUL, Minn., April 23, 2026 Astrin Biosciences announced that it has received accreditation from the College of American...
BASEL, Switzerland, April 13, 2026 Roche has announced that its Elecsys® Neurofilament Light Chain (NfL) blood test has received...
